Further expanded the normal sample size revealed that NCAPG2 was aberrantly highly expressed in practically the entire spectrum of cancers except KIRP, KICH, THCA (Figure 1B), among which, the most significant of these cancers tend to be LGG (p=1.1e-186), LUAD (p=6.8e-79), LUSC (p=1.5e-124), and BRCA (p=2.8e-94). Here, NCAPG2 is linked to cancer.